| Basic Medical Information |
| Common Brand Name |
| Altace |
Norvasc |
| Drug Class |
| Ace Inhibitors |
Calcium-channel Blockers |
| Legal Status |
| Pom (uk), Rx-only (us) |
Pom (uk), Rx-only (us) |
| Possible Side Effects |
| Low Blood Sugar, Dry Cough, Dizziness, Tiredness, Mouth Dryness, Nausea, Vomiting, Diarrhea, Fainting, Change In Amount Of Urine, Yellowing Of Eyes Or Skin, Dark Urine, Abdominal Pain, Neutropenia, Impotence |
Headache, Swelling, Dizziness, Flushing, Fatigue, Nausea, Palpitations |
| Precautions & Contraindications |
| Angina, Atherosclerosis, Mitral Insufficiency, Renovascular Hypertension, Diabetic Or Nondiabetic Nephropathy, Erythrocytosis |
Angina, Arrhythmia, Surgery, Kidney Disease, Bleeding Disorder, Allergies, Pregnant, Breastfeeding |
| Excretion |
| Renal, Fecal |
Renal |
|
| Dosage, Usage and Forms |
| Route of Administration |
| Oral |
Oral |
| Dosage |
| 2.5 Mg |
|
| Maximum daily dose |
| 20 mg |
|
| Forms |
| Capsule |
Tablet |
| Tablet Formulations |
|
2.5 Mg, 5 Mg, 10 Mg |
| Capsule Formulations |
| 1.25 Mg, 2.5 Mg, 5 Mg, 10 Mg |
|
| Chemical Data |
| Molecular mass (g/mol) |
| 416.51 g/mol |
408.88 g/mol |
| Half Life (hours) |
| 4 |
50 |
| Chemicals |
| Carbon, Hydrogen, Nitrogen, Oxygen |
Carbon, Hydrogen, Nitrogen, Oxygen, Chlorine |
| Formula |
| C23h32n2o5 |
C20h25cln2o5 |
| Melting Point (C) |
| 109 C |
179 C |
| Phase (solid/liquid) |
| Solid |
Solid |